1/38

Treating MDR-TB in Tajikistan, Dushanbe, Oct 2013

Patients with tuberculosis must undergo lengthy, arduous treatment regimens in the best of times. When stricken with multidrug-resistant tuberculosis, or MDR-TB, however, the road back to health is even more difficult.

This is because MDR-TB, which develops when prior cases of TB were treated incompletely or incorrectly, does not respond to the customary first-line tuberculosis drugs. With case numbers growing at an unprecedented clip, and with the highly contagious disease transmitting from person to person in some cases — MDR-TB is now a legitimate public health crisis. And yet the reaction of the global medical community has been slow, vague, and inefficient, particularly when it comes to developing better treatment options for MDR-TB patients.

The most neglected are children living with MDR-TB. In Tajikistan, one of Asia’s poorest countries, MSF runs a paediatric TB program.

MSBSTO78

Linked assets

Treating MDR-TB in Tajikistan, Dushanbe, Sept 2013

Treating MDR-TB in Tajikistan, Dushanbe, Sept 2013 (MSB1777)

Treating MDR-TB in Tajikistan, Dushanbe, Sept 2013

2013

Conceptually similar

Fatal Neglect MDR-TB

Treating pediatric TB in Tajikistan

Treating pediatric TB in Tajikistan: Surayo's story

Pediatric TB project in Dushanbe starts first patient on new TB treatmentTajikistan - Pediatric TB project in Dushanbe starts first patient on new TB treatment